Phase II Study of Docetaxel and Trametinib in Patients with <i>KRAS</i> Mutation Positive Recurrent Non–Small Cell Lung Cancer (NSCLC; SWOG S1507, NCT-02642042)Shirish M. Gadgeel, Karen Kelly, Jonathan W. Riess et al.|Clinical Cancer Research|2023Cited by 21